CXCL11 and cancer: A further study showed substantially higher levels of cellular and mitochondrial ROS in TRIP-Br1 suppressed MCF7 cells under both basal conditions and upon STS exposure (Figures 2L-2M), suggesting that TRIP-Br1 could suppress cellular ROS levels in cancer cells.